27-Mar-2026
No headlines found.
Business Wire (Wed, 11-Mar 12:31 PM ET)
Business Wire (Wed, 11-Mar 12:00 PM ET)
Business Wire (Tue, 10-Mar 8:27 PM ET)
Business Wire (Tue, 24-Feb 7:00 AM ET)
Orthofix to Participate in Upcoming Investor Conferences
Business Wire (Tue, 10-Feb 7:00 AM ET)
Fox Factory Announces Strategic Board Refresh
Globe Newswire (Mon, 9-Feb 4:05 PM ET)
Orthofix to Report Fourth Quarter and Full-Year 2025 Financial Results
Business Wire (Tue, 3-Feb 7:00 AM ET)
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
Business Wire (Fri, 9-Jan 7:00 AM ET)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
Orthofix Medical trades on the NASDAQ stock market under the symbol OFIX.
As of March 27, 2026, OFIX stock price declined to $11.50 with 228,947 million shares trading.
OFIX has a beta of 1.15, meaning it tends to be more sensitive to market movements. OFIX has a correlation of 0.24 to the broad based SPY ETF.
OFIX has a market cap of $455.40 million. This is considered a Small Cap stock.
Last quarter Orthofix Medical reported $220 million in Revenue and $.24 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.12.
In the last 3 years, OFIX traded as high as $21.60 and as low as $9.58.
The top ETF exchange traded funds that OFIX belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.
OFIX has underperformed the market in the last year with a return of -28.8%, while the SPY ETF gained +13.1%. In the last 3 month period, OFIX fell short of the market, returning -24.5%, while SPY returned -7.9%. However, in the most recent 2 weeks OFIX has outperformed the stock market by returning -1.7%, while SPY returned -4.0%.
OFIX support price is $11.46 and resistance is $12.13 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OFIX shares will trade within this expected range on the day.